NTLA

$11.109.83%-1.21

After Hours: 11.03-0.07 -0.63%

Intellia Therapeutics Inc (NTLA)

Intellia Therapeutics Inc Stock (NTLA) Forecast

The Intellia Therapeutics Inc (NTLA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $6.99, representing a -37.06% decrease from the current price of $11.10. The highest analyst price target is $12.62, and the lowest is $1.35.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month NTLA Price Target

Average 30.94 (+178.73% Downside)

Is Intellia Therapeutics Inc (NTLA) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	42.71	Neutral
STOCH(9,6)	44.08	Neutral
STOCHRSI(14)	7.41	Buy
MACD(12,26)	-0.05	Sell
ADX(14)	12.73	Neutral
William %R	-84.52	Buy
CCI(14)	-62.39	Neutral

Buy: 2 · Sell: 1 · Neutral: 4Summary: Neutral

Moving Averages

Period	Simple	Exponential
MA10	12.07 Sell	11.94 Sell
MA20	11.93 Sell	11.98 Sell
MA50	12.13 Sell	12.13 Sell
MA100	12.71 Sell	12.42 Sell
MA200	13.06 Sell	12.72 Sell

Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, NTLA could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on NTLA, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 42.71 indicates that NTLA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 44.08 indicates that NTLA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 7.41 indicates that NTLA is oversold. This suggests that NTLA price is at or near the lowest level relative to its recent price history.
ADX (Average Directional Index): The ADX value of 12.73 suggests that there may be some movement in price, but it lacks strength or conviction.
CCI (Commodity Channel Index): A CCI(14) value of -62.39 indicates that NTLA is still oversold but not to an extreme extent.

Long-term NTLA price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Intellia Therapeutics Inc financial reports and earnings history, Intellia Therapeutics Inc (NTLA) stock could reach $39.85 by 2030, $210.11 by 2040 and $495.33 by 2050. See the projected annual prices until 2050 of the Intellia Therapeutics Inc stock below:

Intellia Therapeutics Inc (NTLA) is expected to reach an average price of $90.93 in 2035, with a high prediction of $116.60 and a low estimate of $92.07. This indicates an +719.15% change from the last recorded price of $11.10.
Intellia Therapeutics Inc (NTLA) stock is projected to chart a bullish course in 2040, with an average price target of $172.47, representing an +1,454% change from its current level. The forecast ranges from a conservative $174.76 to a sky-high $210.11.
Our analysts predict Intellia Therapeutics Inc (NTLA) to change +2,450% by 2045, soaring from $282.11 to an average price of $283.00, potentially reaching $343.87. While $282.11 is the low estimate, the potential upside is significant.
Intellia Therapeutics Inc (NTLA) stock is expected to climb by 2050, reaching an average of $410.59, a +3,599% change from its current level. However, a wide range of estimates exists, with high and low targets of $495.33 and $414.36, respectively, highlighting the market's uncertainty.

Intellia Therapeutics Inc Stock (NTLA) Year by Year Forecast

Intellia Therapeutics Inc Stock (NTLA) Price Forecast for 2026

The predicted value for Intellia Therapeutics Inc (NTLA) in 2026 is set at an average of $12.12. Estimates vary from a peak of $24.00 to a trough of $1.35, indicating an +9.19% surge from the present price of $11.10.

Month	Average	Low	High	Change from today's price
December, 2026	$9.47	$1.35	$12.62	-14.68%

Intellia Therapeutics Inc Stock (NTLA) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Intellia Therapeutics Inc (NTLA) is $44.76, with a high forecast of $61.59 and a low forecast of $0.2907. This indicates an +303.27% increase from the last price of $11.10.

Month	Average	Low	High	Change from today's price
January, 2027	$34.34	$0.2907	$25.38	+209.41%
February, 2027	$22.97	$23.95	$22.85	+106.94%
March, 2027	$51.26	$18.72	$43.89	+361.77%
April, 2027	$34.94	$37.62	$37.25	+214.79%
May, 2027	$61.66	$48.65	$55.48	+455.48%
June, 2027	$61.61	$62.36	$59.89	+455.08%
July, 2027	$52.87	$64.65	$61.59	+376.30%
August, 2027	$39.29	$44.51	$51.33	+253.93%
September, 2027	$46.66	$42.72	$34.73	+320.37%
October, 2027	$37.05	$45.26	$40.73	+233.75%
November, 2027	$47.27	$43.72	$42.22	+325.89%
December, 2027	$47.23	$46.08	$44.01	+325.48%

Intellia Therapeutics Inc Stock (NTLA) Price Forecast for 2028

In 2028, Intellia Therapeutics Inc (NTLA) is projected to reach an average price of $48.10, with a high projection of $59.02 and a low estimate of $40.42. This indicates an +333.29% rise from the last price of $11.10.

Month	Average	Low	High	Change from today's price
January, 2028	$50.21	$49.46	$48.33	+352.30%
February, 2028	$59.96	$58.35	$59.02	+440.19%
March, 2028	$51.75	$58.46	$55.62	+366.18%
April, 2028	$51.52	$51.74	$50.32	+364.16%
May, 2028	$50.22	$51.18	$50.76	+352.42%
June, 2028	$50.42	$53.33	$51.22	+354.27%
July, 2028	$44.72	$45.05	$49.60	+302.88%
August, 2028	$41.97	$44.76	$46.16	+278.07%
September, 2028	$44.44	$41.79	$42.38	+300.37%
October, 2028	$42.34	$40.42	$40.40	+281.42%
November, 2028	$42.99	$43.15	$42.07	+287.32%
December, 2028	$46.61	$42.54	$43.12	+319.89%

Intellia Therapeutics Inc Stock (NTLA) Price Forecast for 2029

The 2029 price forecast for Intellia Therapeutics Inc Stock (NTLA) is $42.48 on average, with a high prediction of $51.63 and a low estimate of $34.64. This represents an +282.68% increase from the previous price of $11.10.

Month	Average	Low	High	Change from today's price
January, 2029	$53.99	$47.50	$49.53	+386.44%
February, 2029	$47.56	$52.04	$51.63	+328.47%
March, 2029	$45.19	$45.36	$43.72	+307.08%
April, 2029	$44.69	$42.65	$42.28	+302.63%
May, 2029	$45.60	$47.01	$44.91	+310.79%
June, 2029	$37.29	$43.72	$41.90	+235.97%
July, 2029	$40.06	$36.74	$39.40	+260.90%
August, 2029	$45.33	$42.86	$43.24	+308.42%
September, 2029	$38.40	$39.69	$43.33	+245.95%
October, 2029	$38.56	$39.33	$39.19	+247.36%
November, 2029	$36.22	$36.33	$38.61	+226.33%
December, 2029	$36.83	$34.64	$36.56	+231.79%

Intellia Therapeutics Inc Stock (NTLA) Price Forecast for 2030

Intellia Therapeutics Inc Stock (NTLA) is expected to reach an average price of $37.03 in 2030, with a high forecast of $39.85 and a low forecast of $31.31. This signifies an +233.63% surge from the last price of $11.10.

Month	Average	Low	High	Change from today's price
January, 2030	$35.91	$36.70	$35.76	+223.55%
February, 2030	$38.52	$36.41	$35.67	+247.02%
March, 2030	$40.82	$37.54	$38.06	+267.70%
April, 2030	$37.57	$39.02	$39.82	+238.48%
May, 2030	$39.75	$39.24	$39.30	+258.08%
June, 2030	$40.74	$39.27	$39.85	+267.05%
July, 2030	$36.23	$37.51	$38.73	+226.39%
August, 2030	$37.92	$38.42	$37.11	+241.66%
September, 2030	$37.85	$38.35	$38.36	+241.00%
October, 2030	$35.49	$35.49	$35.81	+219.70%
November, 2030	$34.04	$34.35	$34.35	+206.68%
December, 2030	$29.55	$31.31	$32.64	+166.20%

Similar to NTLA